SARA KILGORE: Open Payments
NPI 1851063994 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,280 in 60 payments from 31 companies in 2025. Trend: 2023 $161 · 2024 $1,816 · 2025 $1,280
Food & beverage: $1,280
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $134 |
| Daiichi Sankyo Inc. | 5 | $124 |
| Novartis Pharmaceuticals Corporation | 5 | $118 |
| E.R. Squibb & Sons, L.L.C. | 6 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| ABBVIE INC. | 4 | $71 |
| TerSera Therapeutics LLC | 2 | $50 |
| BeOne Medicines USA, Inc. | 2 | $44 |
| Celgene Corporation | 2 | $42 |
| Astellas Pharma US Inc | 2 | $42 |
Products named: KEYTRUDA, OPDIVO, DATROWAY, Nubeqa, BRUKINSA, Xospata, Lenvima, OPDUALAG.
Industry payments across NC — which companies pay providers there.
